Sinopharm Tech Holdings Limited reported earnings results for the first quarter ended September 30, 2022. For the first quarter, the company reported sales was HKD 5.63 million compared to HKD 1.68 million a year ago. Net income was HKD 4.38 million compared to net loss of HKD 9.4 million a year ago.

Basic earnings per share from continuing operations was HKD 0.025 compared to basic loss per share from continuing operations of HKD 0.0525 a year ago.